Weekly Research Analyst Ratings Updates for Fresenius Medical Care AG & Co. KGaA (FME)

0

Fresenius Medical Care AG & Co. KGaA (ETR: FME) recently received a number of price target changes and ratings updates:

  • 5/11/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €75.00 ($78.95) from analysts at UBS Group AG.
  • 5/10/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €62.00 ($65.26) from analysts at Warburg Research.
  • 5/5/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €58.00 ($61.05) from analysts at Deutsche Bank Rese….
  • 05/05/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €61.00 ($64.21) from analysts at Credit Suisse Group AG.
  • 05/05/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €83.40 ($87.79) from analysts at Berenberg Bank.
  • 5/4/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €48.70 ($51.26) from analysts at JPMorgan Chase & Co..
  • 04/29/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €83.40 ($87.79) from analysts at Berenberg Bank.
  • 04/27/2022 – Fresenius Medical Care AG & Co. KGaA has been given a new price target of €48.70 ($51.26) by analysts at JPMorgan Chase & Co..
  • 26/04/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €68.00 ($71.58) from analysts at Barclays PLC.
  • 04/26/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €75.00 ($78.95) from analysts at UBS Group AG.
  • 03/23/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €83.40 ($87.79) from analysts at Berenberg Bank.
  • 03/22/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €71.00 ($74.74) from analysts at The Goldman Sachs Group, Inc..
  • 03/22/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €58.00 ($61.05) from analysts at Deutsche Bank Aktiengesellschaft.
  • 03/22/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €75.00 ($78.95) from analysts at UBS Group AG.
  • 03/21/2022 – Fresenius Medical Care AG & Co. KGaA has been given a new price target of €48.70 ($51.26) by analysts at JPMorgan Chase & Co..
  • 03/17/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €83.40 ($87.79) from analysts at Berenberg Bank.
  • 03/16/2022 – Fresenius Medical Care AG & Co. KGaA has received a new price target of €75.00 ($78.95) from analysts at UBS Group AG.

Shares of ETR: FME open at €58.60 ($61.68) on Thursday. The company has a 50-day moving average of €59.87 and a 200-day moving average of €58.49. The company has a market capitalization of $17.17 billion and a P/E ratio of 17.71. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €50.98 ($53.66) and a 12-month high of €71.14 ($74.88). The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt ratio of 95.29.

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Read more



Get news and reviews for Fresenius Medical Care AG & Co KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co KGaA and related companies with MarketBeat.com’s free daily email newsletter.

Share.

Comments are closed.